Technology area: Chemistry & Materials
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Octane Biotech Inc. is focused on the Chemistry & Materials technology area. The company currently has 3 pending office actions. These actions are spread across 3 distinct art units, showing a high degree of technical variance for a small number of filings. Prosecution involves 3 distinct examiners, matching the number of pending actions.
DANIELLE B HENKEL is the busiest examiner, managing 1 pending action. This ratio of the 3 pending actions to the 3 distinct examiners and the 3 distinct art units indicates that every pending matter is being treated as a unique technical and personnel assignment.
This high level of dispersion across the art units means that the company's Chemistry & Materials filings are being reviewed in completely different technical environments. With the distinct examiners involved, there is no opportunity for a single examiner to develop a comprehensive understanding of the company's broader technology. Practitioners must be prepared for three separate prosecution paths, each with its own examiner and art unit requirements.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 3 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HENKEL, DANIELLE B | 1 | 56.4% | +23.4% |
| MUTREJA, JYOTI NAGPAUL | 1 | 81.1% | +4.0% |
| SINES, BRIAN J | 1 | 80.1% | +5.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17635638 | PROCESS CONTROL SYSTEMS FOR AUTOMATED CELL ENGINEERING SYSTEMS | SINES, BRIAN J | 10d overdue |
| 18754402 | CELL CULTURE AND TISSUE ENGINEERING SYSTEMS WITH CONTROLLED ENVIRONMENTAL ZONES | HENKEL, DANIELLE B | — |
| 18354770 | CELL CULTURE CHAMBER FOR INCREASED CELL YIELD | MUTREJA, JYOTI NAGPAUL | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18754402 | CELL CULTURE AND TISSUE ENGINEERING SYSTEMS WITH CONTROLLED ENVIRONMENTAL ZONES | HENKEL, DANIELLE B | — |
| Art Unit | Apps |
|---|---|
| 1799 | 1 |
| 1798 | 1 |
| 1796 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18754402 | CELL CULTURE AND TISSUE ENGINEERING SYSTEMS WITH CONTROLLED ENVIRONMENTAL ZONES | HENKEL, DANIELLE B | 1799 | §102§103§112 | Non-Final OA | — | Pending | Jun 26, 2024 |
| 18354770 | CELL CULTURE CHAMBER FOR INCREASED CELL YIELD | MUTREJA, JYOTI NAGPAUL | 1798 | §102§103 | Non-Final OA | — | Pending | Jul 19, 2023 |
| 17635638 | PROCESS CONTROL SYSTEMS FOR AUTOMATED CELL ENGINEERING SYSTEMS | SINES, BRIAN J | 1796 | §102§103 | Final Rejection | 10d overdue | Pending | Feb 15, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialOctane Biotech Inc. has 3 pending office actions as of October 2026, spread across 3 art units and 3 examiners.
Danielle B Henkel has the most, with 1 of Octane Biotech Inc.'s pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
